NFE2L2 and benign prostatic hyperplasia: According to the roles of the NF-κB and Nrf-2/HO-1 signaling pathways, PCE exerts anti-inflammatory effects and improves oxidative stress, thereby ameliorating BPH by regulating inflammatory and oxidative stress-mediated prostatic inflammation and cell proliferation in the prostate.